Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anlon HealthcareNSE:AHCL +1.26%23 Days Payable is 58.26 as of Jun. 2026, which is 46% below its 10-year median of 107.37. GuruFocus rates NSE:AHCL with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 924 Drug Manufacturers companies, Anlon Healthcare ranks worse than 64.18% on this metric.
The historical rank and industry rank for Anlon Healthcare's Days Payable or its related term are showing as below:
NSE:AHCL'
s Days Payable Range Over the Past 10 Years
Min: 64.9 Med: 107.37 Max: 226.9
Current: 64.9
During the past 5 years, Anlon Healthcare's highest Days Payable was 226.90. The lowest was 64.90. And the median was 107.37.
NSE:AHCL's Days Payable is ranked worse than 64.18% of 924
companies
in the Drug Manufacturers industry
Industry Median: 88.845
vs NSE:AHCL: 64.90
Anlon Healthcare's Days Payable
declined
from Jun. 2025 (74.00) to Jun. 2026 (58.26).
It may suggest that Anlon Healthcareaccelerated paying its suppliers.
The historical data trend for Anlon Healthcare's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Anlon Healthcare's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anlon Healthcare Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Anlon Healthcare's Days Payable distribution charts can be found below:
* The bar in red indicates where Anlon Healthcare's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Anlon Healthcare's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anlon Healthcare (NSE:AHCL) has a Days Payable of 58.26 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Anlon Healthcare and its competitors. This is 46% below median its historical median of 107.37. Over the past decade, Anlon Healthcare's Days Payable has ranged from 64.90 to 226.90. According to the industry distribution chart, Anlon Healthcare ranks #593 out of 924 companies in the Drug Manufacturers industry, placing it in the top 64.2%.
Is Anlon Healthcare's Days Payable too high?
Anlon Healthcare's current Days Payable of 58.26 is 46% below median its 10-year median of 107.37. Over the past 10 years, this metric has ranged from a low of 64.90 to a high of 226.90. The Drug Manufacturers industry median Days Payable is 88.85. Anlon Healthcare's value of 58.26 is 34.4% below this industry median. Based on the distribution chart, Anlon Healthcare ranks #593 out of 924 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Anlon Healthcare has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Anlon Healthcare ranks #593 out of 924 companies for Days Payable. This places Anlon Healthcare in the lower half of its industry. The industry median Days Payable is 88.85. Anlon Healthcare's value of 58.26 is 34.4% below this benchmark. Historically, Anlon Healthcare's own Days Payable has ranged from 64.90 to 226.90 over the past decade. While the company's 10-year median is 107.37 vs. the industry median of 88.85, Anlon Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.85, based on 924 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anlon Healthcare's current Days Payable of 58.26 is 34.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Anlon Healthcare and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anlon Healthcare's current Days Payable is 58.26, which is 46% below median its own 10-year median of 107.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Days Payable of 58.26. The current Days Payable is 58.26, which is 46% below median its 10-year median of 107.37 and 34.4% below the Drug Manufacturers industry median of 88.85. Anlon Healthcare's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Days Payable is 58.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
23GF Score
Get the complete analysis for NSE:AHCL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AHCL has been successfully added to your 
